Doctor Matteo Beltrami
Careggi, Florence (Italy)
The role of fibrosis and inflammation for response and outcome prediction in candidates to cardiac resynchronization therapy: is response the right answer?
Event: ESC Congress 2024
Topic: Cardiac Resynchronisation Therapy (CRT)
Session: Devices in heart failure: new findings
Relation of QRS duration to response to cardiac resynchronization therapy in patients with left bundle branch block
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Cardiac resynchronisation therapy
Session: Devices / CRT/ ICD / Surgery
Dynamic variation of renal function and novel or old HF biomarkers (ST2, Galectin 3, NT-proBNP) and response to cardiac resynchronization therapy (CRT)
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Cardiac resynchronisation therapy
Session: Devices / CRT/ ICD / Surgery
Multi-biomarkers laboratory strategy for outcome prediction in patients with severe systolic dysfunction submitted to CRT
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Cardiac resynchronisation therapy
Session: Devices / CRT/ ICD / Surgery
Additional value of Galectin-3 respect to BNP in acute heart failure patients with preserved ejection fraction
Event: HEART FAILURE 2016
Topic: HFpEF - Heart failure with preserved ejection fraction
Session: HFpEF - Heart failure with preserved ejection fraction
